Femasys Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
Femasys Inc. (FEMY) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $232.78 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-14
- Femasys Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $114.59K, a 10.90% decline year-over-year.
- Femasys Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $118.18K, a 10.61% decline year-over-year.
- Femasys Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $122.22K, a 10.18% decline year-over-year.
- Femasys Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $125.38K, a 10.08% decline year-over-year.
- Femasys Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $508.42K, a 11.53% decline from fiscal 2024.
- Femasys Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $574.68K, a 35.38% increase from fiscal 2023.
- Femasys Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $424.50K, a 29.46% increase from fiscal 2022.
- Femasys Inc. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $327.91K, a 12.14% decline from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $114.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $232.78K 10-Q · filed 2026-08-14 | $355.00K derived: sum of 3 quarters · filed 2026-08-14 | $480.38K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $118.18K 10-Q · filed 2026-05-08 | $240.40K derived: sum of 2 quarters · filed 2026-05-08 | $365.78K derived: sum of 3 quarters · filed 2026-05-08 | $494.39K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $122.22K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $247.60K derived: sum of 2 quarters · filed 2026-03-31 | $376.21K derived: sum of 3 quarters · filed 2026-08-14 | $508.42K 10-K · filed 2026-03-31 |
| 2025-09-30 | $125.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $253.99K derived: sum of 2 quarters · filed 2026-08-14 | $386.20K 10-Q · filed 2025-11-14 | $522.28K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $128.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $260.82K 10-Q · filed 2026-08-14 | $396.90K derived: sum of 3 quarters · filed 2026-08-14 | $536.33K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $132.21K 10-Q · filed 2026-05-08 | $268.29K derived: sum of 2 quarters · filed 2026-05-08 | $407.72K derived: sum of 3 quarters · filed 2026-05-08 | $554.23K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $136.08K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $275.51K derived: sum of 2 quarters · filed 2026-03-31 | $422.02K derived: sum of 3 quarters · filed 2026-03-31 | $574.68K 10-K · filed 2026-03-31 |
| 2024-09-30 | $139.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $285.94K derived: sum of 2 quarters · filed 2025-11-14 | $438.60K 10-Q · filed 2025-11-14 | $588.95K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $146.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $299.17K 10-Q · filed 2025-08-08 | $449.52K derived: sum of 3 quarters · filed 2025-08-08 | $575.13K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $152.66K 10-Q · filed 2025-05-08 | $303.01K derived: sum of 2 quarters · filed 2025-05-08 | $428.63K derived: sum of 3 quarters · filed 2025-05-08 | $501.53K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $150.35K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $275.96K derived: sum of 2 quarters · filed 2025-03-27 | $348.87K derived: sum of 3 quarters · filed 2025-03-27 | $424.50K 10-K · filed 2025-03-27 |
| 2023-09-30 | $125.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $198.52K derived: sum of 2 quarters · filed 2024-11-12 | $274.16K 10-Q · filed 2024-11-12 | $352.09K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $72.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $148.54K 10-Q · filed 2024-08-08 | $226.48K derived: sum of 3 quarters · filed 2024-08-08 | $306.77K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $75.64K 10-Q · filed 2024-05-09 | $153.57K derived: sum of 2 quarters · filed 2024-05-09 | $233.86K derived: sum of 3 quarters · filed 2024-05-09 | $317.31K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $77.94K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $158.23K derived: sum of 2 quarters · filed 2024-03-28 | $241.67K derived: sum of 3 quarters · filed 2024-03-28 | $327.91K 10-K · filed 2024-03-28 |
| 2022-09-30 | $80.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $163.74K derived: sum of 2 quarters · filed 2023-11-14 | $249.97K 10-Q · filed 2023-11-14 | $338.67K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $83.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $169.68K 10-Q · filed 2023-08-10 | $258.38K derived: sum of 3 quarters · filed 2023-08-10 | $349.61K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $86.23K 10-Q · filed 2023-05-11 | $174.93K derived: sum of 2 quarters · filed 2023-07-24 | $266.16K derived: sum of 3 quarters · filed 2023-07-24 | $361.20K derived: sum of 4 quarters · filed 2023-07-24 |
| 2021-12-31 | $88.70K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-07-24 | $179.93K derived: sum of 2 quarters · filed 2023-07-24 | $274.96K derived: sum of 3 quarters · filed 2023-07-24 | $373.22K 10-K/A · filed 2023-07-24 |
| 2021-09-30 | $91.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $186.26K derived: sum of 2 quarters · filed 2022-11-10 | $284.52K 10-Q · filed 2022-11-10 | $385.45K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $95.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $193.29K 10-Q · filed 2022-08-10 | $294.22K derived: sum of 3 quarters · filed 2022-08-10 | $397.88K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $98.26K 10-Q · filed 2022-05-11 | $199.18K derived: sum of 2 quarters · filed 2022-05-11 | $302.85K derived: sum of 3 quarters · filed 2022-05-11 | |
| 2020-12-31 | $100.93K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $204.59K derived: sum of 2 quarters · filed 2022-03-24 | $421.11K 10-K · filed 2022-03-24 | |
| 2020-09-30 | $103.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $320.18K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $216.52K 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |